JP2014500960A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500960A5 JP2014500960A5 JP2013538809A JP2013538809A JP2014500960A5 JP 2014500960 A5 JP2014500960 A5 JP 2014500960A5 JP 2013538809 A JP2013538809 A JP 2013538809A JP 2013538809 A JP2013538809 A JP 2013538809A JP 2014500960 A5 JP2014500960 A5 JP 2014500960A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- subject
- bin1
- level
- skeletal muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41168310P | 2010-11-09 | 2010-11-09 | |
| US61/411,683 | 2010-11-09 | ||
| PCT/US2011/059574 WO2012087437A2 (en) | 2010-11-09 | 2011-11-07 | Bin1 expression as a marker of skeletal muscle mass and neurological conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500960A JP2014500960A (ja) | 2014-01-16 |
| JP2014500960A5 true JP2014500960A5 (enExample) | 2014-12-25 |
| JP5866126B2 JP5866126B2 (ja) | 2016-02-17 |
Family
ID=46314702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013538809A Active JP5866126B2 (ja) | 2010-11-09 | 2011-11-07 | 骨格筋量および神経性状態のマーカーとしてのｂｉｎ１発現 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9891232B2 (enExample) |
| EP (1) | EP2638403B1 (enExample) |
| JP (1) | JP5866126B2 (enExample) |
| AU (2) | AU2011345312A1 (enExample) |
| CA (1) | CA2817519C (enExample) |
| WO (1) | WO2012087437A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120094300A1 (en) | 2009-04-24 | 2012-04-19 | Robin Shaw | Bin1 as a Prognostic Marker in Cardiovascular Disease |
| US8999659B2 (en) | 2010-10-20 | 2015-04-07 | The Regents Of The University Of California | Body fluid BIN1 as a marker of cardiac health |
| CA2850178C (en) | 2011-09-30 | 2020-02-25 | Sarcotein Diagnostics, Llc | Bin1 expression as a marker of cancer |
| HK1246394A1 (zh) | 2015-03-02 | 2018-09-07 | Sarcotein Diagnostics Llc | 13+/17+bin1表达作为心脏病症的标记 |
| JP6539511B2 (ja) * | 2015-06-17 | 2019-07-03 | 花王株式会社 | 運動機能の判定用マーカー |
| JP6886241B2 (ja) * | 2016-01-07 | 2021-06-16 | 味の素株式会社 | 骨格筋面積の評価方法 |
| MX2018013384A (es) * | 2016-05-02 | 2019-02-28 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau. |
| WO2020023679A1 (en) * | 2018-07-25 | 2020-01-30 | Accurus Biosciences, Inc. | Novel cldn 18.2-specific monoclonal antibodies and methods of use thereof |
| KR20210075132A (ko) | 2018-10-09 | 2021-06-22 | 아이벡스 바이오사이언시스, 엘엘씨 | 필라민-a에 대한 항체 및 이의 치료적 용도 |
| US20240026034A1 (en) * | 2020-12-15 | 2024-01-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Antibodies specific for qsox1 and methods of using the same |
| CN112778414B (zh) * | 2020-12-31 | 2022-04-15 | 中南大学湘雅二医院 | cBIN1抗体及其应用 |
| CN112794900B (zh) * | 2020-12-31 | 2022-10-25 | 中南大学湘雅二医院 | cBIN1抗体及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6048702A (en) * | 1995-05-05 | 2000-04-11 | The Wistar Institute Of Anatomy And Biology | Murine and human box-dependent myc-interacting protein (Bin1) and uses therefor |
| AU5632300A (en) * | 1999-07-07 | 2001-01-30 | Regeneron Pharmaceuticals, Inc. | Methods of inhibiting muscle atrophy |
| US6831063B1 (en) * | 1999-08-31 | 2004-12-14 | The Wistar Institute Of Anatomy And Biology | Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses therefor |
| WO2005037230A2 (en) * | 2003-10-14 | 2005-04-28 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for treating heart failure |
| WO2005113798A2 (en) | 2004-04-15 | 2005-12-01 | University Of Florida Research Foundation, Inc. | Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
| US20060003959A1 (en) * | 2004-06-10 | 2006-01-05 | Steven Burden | Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same |
| WO2008008846A2 (en) * | 2006-07-11 | 2008-01-17 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Differential expression of molecules associated with intra-cerebral hemorrhage |
| US20120094300A1 (en) * | 2009-04-24 | 2012-04-19 | Robin Shaw | Bin1 as a Prognostic Marker in Cardiovascular Disease |
| US8999659B2 (en) * | 2010-10-20 | 2015-04-07 | The Regents Of The University Of California | Body fluid BIN1 as a marker of cardiac health |
-
2011
- 2011-11-07 EP EP11850406.7A patent/EP2638403B1/en active Active
- 2011-11-07 US US13/884,454 patent/US9891232B2/en active Active
- 2011-11-07 CA CA2817519A patent/CA2817519C/en active Active
- 2011-11-07 JP JP2013538809A patent/JP5866126B2/ja active Active
- 2011-11-07 WO PCT/US2011/059574 patent/WO2012087437A2/en not_active Ceased
- 2011-11-07 AU AU2011345312A patent/AU2011345312A1/en not_active Abandoned
-
2017
- 2017-03-10 AU AU2017201661A patent/AU2017201661B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013060443A5 (enExample) | ||
| JP2023002583A (ja) | Ｉｌ２３経路バイオマーカーを使用するｉｌ２３アンタゴニストに対する臨床応答の予測 | |
| CN102816763B (zh) | 特异性结合于疟原虫乳酸脱氢酶pLDH的DNA适体 | |
| JP2013500941A5 (enExample) | ||
| JP2012115275A5 (enExample) | ||
| JP2010115195A5 (enExample) | ||
| JP2012012402A5 (enExample) | ||
| EA201290629A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| WO2009116861A3 (en) | Diagnostic of pre-symptomatic metabolic syndrome | |
| JP2014518883A5 (enExample) | ||
| JP2016029056A5 (enExample) | ||
| JP2013500940A5 (enExample) | ||
| NZ600828A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| JP2016514091A5 (enExample) | ||
| JP2016136963A5 (enExample) | ||
| JP2014502848A5 (enExample) | ||
| EA201291314A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| JP2013539369A5 (enExample) | ||
| JP2014503191A5 (enExample) | ||
| CA2863661C (en) | Diagnostic peptides for lyme disease | |
| WO2015185658A3 (en) | Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers | |
| RU2018103933A (ru) | Моноклональные антитела, с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом | |
| JP2014509860A5 (enExample) | ||
| Lota et al. | Circulating biomarkers of interstitial lung disease in systemic sclerosis | |
| JP2016534022A5 (enExample) |